<i>PPM1D</i> Somatic Mutations in Myeloid Neoplasms: Clinical Profile, Clonal Characteristics and Impact of Concurrent Somatic <i>TP53</i> MutationsTalha Badar, Mrinal M. Patnaik, Naseema Gangat et al.|Blood|2024Cited by 3
Applicability of current prognostication models for MDS patients with DDX41 mutationNadia Toumeh, Aref Al‐Kali, Yazan Jabban et al.|Leukemia Research|2025Cited by 2
Causes of death in DDX41-mutated myeloid neoplasms: A retrospective studyNadia Toumeh, Aref Al‐Kali, Yazan Khair Eldien Jabban et al.|Blood|2025Cited by 0
Interplay between mutant DNMT3A and UBA1 worsens survival through altered inflammatory and metabolic pathwaysJenna Fernandez, Mrinal M. Patnaik, Jérôme Hadjadj et al.|Blood|2025Cited by 0
Distinct advantages for risk scoring models in patients with clonal cytopenia of undetermined significanceYazan Jabban, Aref Al‐Kali, Rong He et al.|British Journal of Haematology|2026Cited by 0